FOR CLINICIANS

Your patients show up. We make sure they’re ready.

Prep under clinical control, right before the procedure. Predictable results. Fewer cancellations. Cleaner procedures.

Day-of cancellations due to inadequate prep are a persistent source of lost revenue and schedule disruption. ZeraFlow is designed to significantly reduce that variable by standardizing preparation in a controlled clinical setting. The result: fewer last-minute gaps, more reliable daily throughput, and the flexibility to fill open slots on shorter notice

THE PROBLEM

This isn’t a patient problem. It’s a system failure.

Up to 35%

of colonoscopies are compromised by inadequate bowel preparation in real-world practice — typically discovered only at the start of the procedure.

10–15%

of scheduled procedures are cancelled or delayed on the day of the procedure due to prep failure, directly impacting revenue and schedule efficiency.³

47%

reduction in small adenoma detection in poorly prepped colons — undermining the clinical value of every compromised procedure.²

$1,100–$2,150

cost of a single repeat colonoscopy due to poor prep — a direct consequence of a system that relies entirely on unsupervised at-home compliance.

International ZeraFlow Data

International Peer-Reviewed Clinical Data

93.6%

Prep adequacy rate

98.4%

Prep protocol completion rate in published clinical study

Zero device-related serious adverse events

Zero

~10 min

Estimated procedure time saved per colonoscopy

Integrates into your existing workflow in four steps

  • Patient arrives

    Mild laxative tablets the night before. No large-volume oral prep required.

  • Prep area (~200 sq ft)

    Standard water connection and drainage outlet. Minimal space required.

  • Staff-supervised cleanse

    ~30–40 min warm-water irrigation. Single-use sleeve. Prep adequacy confirmed before scope insertion.

  • Proceed to colonoscopy

    Designed to deliver consistent, full-colon cleansing.

ZeraFlow converts prep from a liability into a revenue-generating clinical step

PRACTICE ECONOMICS

What you invest
What you gain
Competitive per-procedure kit pricing — available on request
Reduce day-of cancellation revenue loss
Flexible equipment leasing options available
Designed to significantly reduce costly repeat colonoscopy scheduling
8 to 10 procedures per day per system
Improve schedule predictability and utilization
No additional physician time required
New prep step revenue opportunity

We are selecting our first U.S. clinic partners.

  • White-glove onboarding

    Equipment installation, workflow integration, and on-site launch support.

  • Clinical staff training and certification

    Full care team training program included at no additional cost.

  • Ongoing clinical support

    Clinical and operational guidance throughout the pilot.

Express Pilot Interest

Tell us about your practice

We are completing FDA clearance and selecting our first U.S. clinic partners. Enter your information and we will notify you as soon as ZeraFlow is available near you.

¹ Ness RM et al. American Journal of Gastroenterology. 2001;96:1797–1802. AND Bucci C et al. World Journal of Gastroenterology. 2014;20(23):6978–6990.
² van Rijn JC et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. American Journal of Gastroenterology. 2006;101(2):343–350. (Published range: 42–48%; 47% is within this range.)
³ Business Plan (internal document only). No primary citation confirmed. For sourced alternative: Jacobson BC et al. Reasons for failure to complete colonoscopy. American Journal of Gastroenterology. ACG Annual Meeting abstract.
⁴⁵⁶ Ziv Y, Scapa E. Techniques in Coloproctology. 2013;17:39–44. DOI: 10.1007/s10151-012-0876-8.
⁷"Based on physician clinical assessment. Individual results may vary. Data from the U.S. clinical pilot, currently in planning, will provide validated procedure time metrics."
ZeraFlow is an investigational device. It has not been cleared or approved by the U.S. FDA and is not currently available for commercial sale in the United States.